Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Retro Walking With and Without Bosu Ball for Balance and Mobility in Hearing Impaired Children

5. mai 2026 oppdatert av: Riphah International University

Comparative Effects of Retro Walking With and Without Bosu Ball on Balance and Mobility in Children With Hearing Impairment

his randomized controlled trial aims to evaluate the effects of retro walking with and without BOSU ball training on balance and mobility in hearing-impaired children aged 8-12 years. A total of 24 participants will be divided into experimental and control groups. The experimental group will receive retro walking along with BOSU ball training, while the control group will perform retro walking only for 8 weeks. Balance and mobility will be assessed using the Pediatric Balance Scale, Timed Up and Go Test, and One-Leg Stance Test. Data will be collected from specialized schools in Lahore and analyzed using SPSS 27. Ethical approval will be obtained prior to study commencement.

Studieoversikt

Status

Rekruttering

Detaljert beskrivelse

Children with hearing impairment often experience balance and motor deficits due to concomitant damage to the vestibular structures. Interventions focusing on balance training have shown promise in improving postural control and motor coordination in this population. Retro walking, or backward walking, has been identified as an effective exercise to enhance balance and motor control. Additionally, the BOSU ball, a fitness training device that provides an unstable surface, is commonly used for balance training. However, the combined effect of retro walking and BOSU ball training on balance and mobility in hearing-impaired children remains underexplored. The aim of this study is to investigate the effects of retro walking on balance and mobility with and without Bosu ball in hearing impaired children.

The study design will be a randomized control trial. Data will be collected from Govt. Deaf and Defective Hearing Model High School for Girls Rajgarh and Deaf Reach School, Training Center and College, Lahore. The study will be completed in 10 months after the approval of synopsis. Children aged 8 to 12 years will be randomly assigned either into the experimental group(n=12) or control group (n=12). The experimental group will be provided retro walking exercises for 30 minutes 8 weeks and BOSU ball will also be 8 weeks duration. The Control group will provide only retro walking exercises for 8 weeks. Participants fulfilling the eligibility criteria will be asked to assign the consent form before entering into the study. Balance will be measured by pediatric balance scale, mobility will be measured by time up and go test and static balance will be measured by one leg stance test. The synopsis will be presented to Research Ethical Committee of Riphah International University, Lahore for ethical approval to conduct this study. Data will be analyzed through SPSS 27.

Studietype

Intervensjonell

Registrering (Antatt)

24

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Rekruttering
        • Govt. Deaf and Defective Hearing Model High School for girls, Rajgarh
        • Ta kontakt med:
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Age 8 to 12 years.
  • Children with hearing loss in right and left ear (bilateral).
  • Children with hearing-impaired intensity over 61 dB.
  • Both genders will be included.
  • Balance cut off value <45 on pediatrics balance scale.

Exclusion Criteria:

  • Presence of neurologic disease.
  • Hyperactivity and vision problems.
  • Have any musculoskeletal disorders.
  • Children with cochlear implant.
  • Children with leg length discrepancy

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Retro walking with bosu ball
The experimental group will receive a structured balance and mobility training program that includes retro walking performed with the use of a Bosu ball. Participants will practice backward walking or the unstable surface of the Bosu ball.
The BOSU ball intervention includes a series of balance and strength exercises performed in both stable (flat side up) and unstable (bouncy side up) positions. Activities involve weight shifting, circular foot movements, squats, single-leg stance, leg abduction, lunges, push-ups, and abdominal crunches to challenge stability. These movements are designed to improve balance, core strength, coordination, and functional mobility under controlled conditions.all these interventions for 8 weeks
Andre navn:
  • Retro Walking
Aktiv komparator: Retro walking without bosu ball
The control group will participate in a conventional balance and mobility training program involving retro walking on a stable, flat surface without the use of a BOSU ball. Participants will perform backward walking only under supervision.
The intervention consists of structured retro walking exercises designed to improve balance, coordination, and mobility. It includes variations such as knee and heel pulling, slalom movements, cross steps, skipping, and fast backward running with different body and foot positions. These activities are performed under supervision to enhance postural control, dynamic stability, and functional walking performance

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Pediatrics Balance Scale
Tidsramme: Baseline, 8weeks
The Pediatric Balance Scale (PBS) is a valid and reliable test used to assess functional balance in children. It includes 14 simple activity-based tasks scored out of 56, where higher scores indicate better balance. The test is quick to administer and commonly used in children with balance impairments, including hearing loss.
Baseline, 8weeks
Time Up and Go Test
Tidsramme: Baseline, 8weeks
The Timed Up and Go Test (TUG) is a reliable and valid tool used to assess functional mobility and dynamic balance in children aged 3-18 years. It has strong test-retest, intra-rater, and inter-rater reliability and correlates well with other measures of balance, strength, and functional ability.
Baseline, 8weeks
Single leg stance test
Tidsramme: Baseline, 8weeks
It is used to assess static balance by measuring how long a child can stand on one leg. The child maintains a specific posture while timing starts when one foot is lifted and stops when balance is lost or the foot touches the ground. Proper posture is required throughout, and the test is repeated if incorrect positioning occurs.
Baseline, 8weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Salma Kanwal, MS-PT, Riphah International University

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

15. april 2026

Primær fullføring (Antatt)

5. juli 2026

Studiet fullført (Antatt)

5. august 2026

Datoer for studieregistrering

Først innsendt

5. mai 2026

Først innsendt som oppfylte QC-kriteriene

5. mai 2026

Først lagt ut (Faktiske)

11. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

11. mai 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

5. mai 2026

Sist bekreftet

1. mai 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere